Hosted on MSN18h
Neurizon sets out to capture the market in neurodegenerative disease therapies
This is the goal which Neurizon Therapeutics Ltd – the company formerly known as PharmAust – is pursuing through development ...
Neurizon Therapeutics Receives Positive Opinion on Orphan Medicinal Product Designation for NUZ-001 in Europe
Neurizon Therapeutics Limited (ASX: NUZ & NUZOA) ("Neurizon" or "the Company"), a clinical-stage biotech company advancing ...
manilatimes3d
ZTE unveils industry's first AI FWA Solution under its upgraded product philosophy GIS 2.0
ZTE Corporation (0763.HK / 000063.SZ), a global leading provider of integrated information and communication technology solutions, has debuted the industry's first AI-powered full-stack FWA solution, ...
Hosted on MSN3d
Neurizon's fast-track application for flagship drug in Europe received 'positively'
While the final decision is set for next month, biotech player Neurizon’s (ASX:NUZ) hopes have been lifted with a view ...
stockhead9d
October Health Winners: Uscom, Respiri lead sluggish sector, but ‘time in the market, not timing, is key’
ASX healthcare stocks underperform, but optimism grows as Uscom, Respiri, Hitiq report mixed results and Artrya, Nyrada make ...
The Australian9d
Spark Plus sees 225pc upside in biotech player Neurizon
Spark Plus, an Asia-Pacific corporate advisory firm, puts a target price of 69.6 cents on Neurizon – a 225% upside to its ...
Neurizon’s strong September quarter to propel treatments for neurodegenerative diseases forward
Clinical-stage biotech Neurizon Therapeutics – formerly PharmAust – made significant strides advancing its treatments for neurodegenerative diseases during the September 2024 quarter.
Finanzen10013d
Service Properties Trust Reg. Shs of Benef. Int. DL-,01 Aktie
Bitte entschuldigen Sie den Fehler. Sollte dieser Fehler erneut auftreten, kontaktieren Sie bitte unseren Kundeservice per E-Mail.
Sydney Morning Herald15d
Punters pile into Red Metal in oversubscribed share plan
Other recent examples extend to Neurizon Therapeutics, a neurodegenerative medical company taking the fight to ...